Helena McMeekin

Helena McMeekin

Auto-generated profile, based on publicly available information

Helena McMeekin

Clinical Physics, Barts Health NHS Trust, London, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
JCJon O. Cleary
Jon O. Cleary
JYJason Yeung
Jason Yeung
HMHelena McMeekin
Helena McMeekin
TWThomas Wilhelm
Thomas Wilhelm
TWThomas Wagner
Thomas Wagner
Radiolabelled somatostatin analogues detect neuroendocrine tumours (NETs), but may reveal other tumour types. We examined the prevalence of possible meningioma in patients with known or suspected NETs imaged with 68Ga-DOTATATE PET-computed tomography (CT) on the basis of central nervous system uptake and compared with findings on magnetic resonance and contrast-enhanced CT imaging. Retrospective imaging reports from 313 patients who had undergone 68Ga-DOTATATE PET imaging for primary or repeat NET staging were searched to identify suspected meningiomas on PET. Images were then compared with findings on subsequent complementary MRI or contrast-enhanced CT scanning (performed within mean±112 days of PET-CT) if available. Of 313 patients, 22 had regions of uptake suggestive of meningioma. MRI was available for 12 patients and contrast-enhanced CT was available for one patient. Of these, one patient with known von Hippel-Lindau syndrome had probable cerebellar NET metastasis. Six patient scans indicated lesions consistent with PET. Two of these reported initially did not comment on meningioma. No obvious lesion was found in the remaining six patients; however, five showed a possible correlation to venous structures. The mean maximum standardized uptake value±SEM for lesions in all 21 probable meningioma patients was 4.90±0.45. 68Ga-DOTATATE is a sensitive marker of probable meningioma and may identify small lesions not reported on subsequent MRI. Lesions clearly observed on PET were identified on review in half of patients where complementary MR or CT imaging was available. Haemangioblastoma and metastatic NETs may have focal peripheral uptake similar to meningioma on 68Ga-DOTATATE PET and should be considered in the differential.

5 November 2020 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
HMHelena McMeekin
Helena McMeekin
FWFred Wickham
Fred Wickham
BFBen Fongenie
Ben Fongenie
MBMaria Burniston
Maria Burniston
Aim: We aimed to investigate the accuracy of a single-sample glomerular filtration rate (SS-GFR) technique with a sample taken at 24 h post-injection for patients with GFR lower than 25 mL/min/1.73 m2. A comparison with the results from same-day slope-intercept GFR (SI-GFR) was also performed. Methods: Data from patients referred for GFR assessment to inform the management of chronic kidney disease at the Royal Free Hospital were reviewed. Four-sample SI-GFR calculation with samples at 2-, 4-, 6-, and 24-h post-injection was taken as the reference measurement to which the Gref and Karp SS-GFR (24-h sample) and same-day SI-GFR (2- and 4-h samples) were compared. The effect of protein binding on GFR accuracy was modelled. Results: A total of 43 GFR examinations with reference GFR less than 25 mL/min/1.73 m2 were included in the analysis. Bland–Altman analysis gave mean differences of 0.4 mL/min/1.73 m2 (95% confidence interval: 0–0.7) for SS-GFR (24 h) and 3.0 mL/min/1.73 m2 (95% confidence interval: 1.9–4.2) for same-day SI-GFR. 95% limits of agreement were –2.0 to 2.8 mL/min/1.73 m2 for SS-GFR (24 h) and –4.0 to 10.1 mL/min/1.73 m2 for same-day SI-GFR. Conclusions: SS-GFR with a 24-h sample is more accurate than same-day SI-GFR in patients with GFR less than 25 mL/min/1.73 m2. Using SS-GFR with a 24-h sample in routine clinical practice will result in clinically insignificant differences in GFR result compared with the reference technique, whereas a same-day SI-GFR measurement could cause large inaccuracies.

26 October 2022 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
HMHelena McMeekin
Helena McMeekin
STSam Townrow
Sam Townrow
MBMark Barnfield
Mark Barnfield
ABAndy Bradley
Andy Bradley
BFBen Fongenie
Ben Fongenie
MBMaria Burniston
Maria Burniston
Background: The 2018 BNMS Glomerular Filtration Rate (GFR) guidelines recommend a single-sample technique with the sampling time dictated by the expected renal function, but this is not known with any accuracy before the test. We aimed to assess whether the sampling regime suggested in the guidelines is optimal and determine the error in GFR result if the sample time is chosen incorrectly. We can then infer the degree of flexibility in the sampling regime. Methods: Data from 6328 patients referred for GFR assessment at 6 different hospitals for a variety of indications were reviewed. The difference between the single-sample (Fleming) GFR result at each sample time and the slope–intercept GFR result at each hospital was calculated. A second dataset of 777 studies from one hospital with nine samples collected from 5 min to 8 h post-injection was analysed to provide a reference GFR to which the single-sample results were compared. Results: Recommended single-sample times have been revised: for an expected GFR above 90 ml/min/1.73m2 a 2-h sample is recommended; between 50 and 90 ml/min/1.73m2 a 3-h sample is recommended; and between 30 and 50 ml/min/1.73m2 a 4-h sample is recommended. Root mean square error in single-sample GFR result compared with slope–intercept can be kept less than or equal to 3.30 ml/min/1.73m2 by following these recommendations. Conclusion: The results of this multisite study demonstrate a reassuringly wide range of sample times for an acceptably accurate single-sample GFR result. Modified recommended single-sample times have been proposed in line with the results, and a lookup table has been produced of rms errors across the full range of GFR results for the three sample times which can be used for error reporting of a mistimed sample.

5 November 2020 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
HMHelena McMeekin
Helena McMeekin
MBMaria T. Burniston
Maria T. Burniston
MBMark Barnfield
Mark Barnfield
APA. Michael Peters
A. Michael Peters
Aim: The aim of this study was to evaluate a slope-intercept glomerular filtration rate (GFR) one-compartment correction method based exclusively on the rate constant ( α 2) of the exponential between 2 and 4 h post-injection that requires no scaling for BSA. Methods: The correction factor is 1/([C. α 2]+1). C depends on the difference between one-compartment-corrected and uncorrected GFR, so varies with different correction procedures. Patients were in four groups: group 1 (51Cr-EDTA; n = 141) and group 2 (99mTc-DTPA; n = 47) had sampling at 2, 3 and 4 h. Groups 3A (99mTc-DTPA; n = 168) and 3B (99mTc-DTPA; n = 361) gave nine samples up to 480 min. C was calculated from GFR corrected using Brochner-Mortensen (BM) without prior BSA-scaling (C BM; GFRBM), after BSA-scaling then reverse-scaling as per British Nuclear Medicine Society (BNMS) guidelines (C BNMS; GFRBNMS), and after correction using the equations containing ‘f’ described by Fleming (C Flem; GFRFlem) and Jodal and Brochner-Mortensen (C JBM; GFRJBM). In group 3A, C (C 9) was determined from GFR measured from all nine samples (GFR9) and from seven samples (C 7) up to 240 min. In 3B, GFRC, corrected using 1/([C 9.α 2]+1), was compared with GFRBM, GFRBNMS, GFRFlem and GFRJBM against GFR9 (gold-standard). Results: C derived from these one-compartment correction formulae ranged from 25 to 32 min. In group 3, C 7 and C 9 were 28 ± 11 and 38 ± 14 min (P < 0.0001). Biases of GFRBM, GFRBNMS, GFRJBM, GFRFlem and GFRC against GFR9 were 2.7, 1.5, 4.2, 3.4 and 0.4 ml/min. Corresponding precisions were 9.3, 7.3, 7.0, 6.7 and 7.6 ml/min. Conclusion: Correction using α 2 avoids BSA scaling, has a low bias against gold-standard GFR and does not over-correct at high GFR.

9 December 2025 in Seminars in Nuclear Medicine
Verified
Journal Article
Open access
JWJames Warwick
James Warwick
JHJennifer Holness
Jennifer Holness
HMHelena McMeekin
Helena McMeekin
For certain clinical scenarios accurate and precise GFR measurement is required. In the majority of situations this is calculated from the plasma clearance of an exogenous marker that undergoes glomerular filtration, using the slope-intercept (SI) or single-sample (SS) methods. This paper is intended to complement a previous Seminars paper with a specific focus on practical ways to avoid potential pitfalls and quality control measures that can be implemented to minimize the risk of GFR measurement errors. The underlying causes of GFR errors can be understood in terms of measurement errors or procedural errors. All measurements are accompanied by inherent errors that are related to the finite precision of the measuring instruments used. Kept within an acceptable range, measurement errors make a small contribution to GFR error when compared to expected biological variation. Procedural errors consist of a diverse group of deviations from correct procedure ranging from selection of an inappropriate methodology through to missteps at many points in the investigation procedure. Procedural errors can significantly affect the accuracy of GFR measurements. Errors are primarily avoided by regular equipment quality control and careful adherence to clear standard operating procedures. Quality control parameters integrated into a calculation spreadsheet can play a useful secondary role to flag potential measurement or procedural errors.

28 October 2021 in Research Square
Verified
Preprint
Open access
PDF file
HMHelena McMeekin
Helena McMeekin
STSam Townrow
Sam Townrow
MBMark Barnfield
Mark Barnfield
ABAndy Bradley
Andy Bradley
BFBen Fongenie
Ben Fongenie
MBMaria Burniston
Maria Burniston
BackgroundThe 2018 BNMS Glomerular Filtration Rate (GFR) guidelines recommend a single-sample technique with the sampling time dictated by the expected renal function, but this is not known with any accuracy before the test. We aimed to assess whether the sampling regime suggested in the guidelines is optimal, and determine the expected error in GFR result if the sample time is chosen incorrectly. We can then infer the degree of flexibility in the sampling regime.Methods Data from 8946 patients referred for GFR assessment at 6 different hospitals for a variety of indications were reviewed. The difference between the single-sample (Fleming) GFR result at each sample time and the slope-intercept GFR result at each hospital was calculated. A second dataset of 775 studies from one hospital with nine samples collected from 5 minutes to 8 hours post injection was analysed to provide a reference GFR to which the single sample results were compared.Results Recommended single-sample times have been revised: for estimated GFR above 80 ml/min/1.73m2 a 2 hour sample is recommended, giving mean difference from slope-intercept GFR of -2.08 ml/min/1.73m2 (1333 GFR tests included). Between 30 and 80 ml/min/1.73m2 a 4 hour sample is recommended, giving a 1.95 ml/min/1.73m2 mean difference (2057 GFR tests included). The standard deviation of the differences is 3.50 ml/min/1.73m2 at 2 hours and 2.56 ml/min/1.73m2 at 4 hours for GFR results in the recommended range. It is 5.81 ml/min/1.73m2 at 2 hours and 5.70 ml/min/1.73m2 at 4 hours for GFR results outside the recommended range. ConclusionThe results of this multisite study demonstrate a reassuringly wide range of sample times for an acceptably accurate single-sample GFR result. Modified recommended single-sample times have been proposed in line with the results, and the reported errors for both sample times can be used for error analysis of a mistimed sample.